Literature DB >> 22842766

Corticosteroid administration reduces the concentration of hyaluronan in bronchoalveolar lavage in a murine model of eosinophilic airway inflammation.

Glenda Ernst1, Silvina Lompardía, Rosalía Cordo Russo, Virginia Gentilini, Stella Venturiello, Fernando Galíndez, Pedro Grynblat, Silvia E Hajos.   

Abstract

OBJECTIVE: To analyze the effect of corticosteroid administration on the concentration of hyaluronan (HA) in bronchoalveolar lavage (BAL) in a murine model of eosinophilic airway inflammation and to study the mechanisms involved.
MATERIALS AND METHODS: Untreated-mice or mice treated with 1 μg/g/day betamethasone (Bm) or 0.25 μg/g/day(-1) budesonide (Bd) were sensitized and challenged with Dermatophagoides pteronyssinus (Dp) or saline (control group). The concentration of HA in BAL was determined by ELISA. In vitro migration assays were performed using a Boyden chamber and the expression of HA synthases (HAS) was analyzed by RT-PCR.
RESULTS: We found a significant increase (P < 0.01) in the levels of HA in BAL from Dp-treated mice that was prevented by Bm or Bd. Corticosteroids also inhibited the increase in HAS expression, and the phosphorylation of Akt and ERK in the lungs of challenged mice. Finally, we found that low molecular weight HA induces the chemotaxis of BAL cells in vitro through a mechanism mediated by CD44.
CONCLUSION: We conclude that corticosteroids prevent the increase in HA in BAL from Dp-challenged mice. This effect is associated with reduced expression of HAS and reduced phosphorylation of Akt and ERK in the lungs of challenged mice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22842766     DOI: 10.1007/s00011-012-0530-y

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  40 in total

1.  CD44--a sticky target for asthma.

Authors:  Marc E Rothenberg
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

Review 2.  The asthma epidemic.

Authors:  Waltraud Eder; Markus J Ege; Erika von Mutius
Journal:  N Engl J Med       Date:  2006-11-23       Impact factor: 91.245

3.  Hyaluronan induces migration of multidrug-resistant lymphoma cell lines in vitro through Tiam1 activation by a PI3K-dependent mechanism.

Authors:  Rosalía I Cordo-Russo; Laura D Alaniz; Natalia Saccodossi; Silvina Lompardía; Guillermo Blanco; Elida Alvarez; Mariana G García; Silvia E Hajos
Journal:  Leuk Res       Date:  2010-03-17       Impact factor: 3.156

4.  Airway inflammation in mild intermittent and in persistent asthma.

Authors:  A M Vignola; P Chanez; A M Campbell; F Souques; B Lebel; I Enander; J Bousquet
Journal:  Am J Respir Crit Care Med       Date:  1998-02       Impact factor: 21.405

5.  Hyaluronan deposition and correlation with inflammation in a murine ovalbumin model of asthma.

Authors:  Georgiana Cheng; Shadi Swaidani; Manisha Sharma; Mark E Lauer; Vincent C Hascall; Mark A Aronica
Journal:  Matrix Biol       Date:  2011-01-18       Impact factor: 11.583

Review 6.  CD44 and its role in inflammation and inflammatory diseases.

Authors:  Pauline Johnson; Brian Ruffell
Journal:  Inflamm Allergy Drug Targets       Date:  2009-07

7.  Murine abortion is associated with enhanced hyaluronan expression and abnormal localization at the fetomaternal interface.

Authors:  R Cordo-Russo; M G Garcia; G Barrientos; A S Orsal; M Viola; P Moschansky; F Ringel; A Passi; L Alaniz; S Hajos; S M Blois
Journal:  Placenta       Date:  2008-12-06       Impact factor: 3.481

8.  Pro- and anti-inflammatory factors cooperate to control hyaluronan synthesis in lung fibroblasts.

Authors:  Thomas S Wilkinson; Susan Potter-Perigo; Christina Tsoi; Leonard C Altman; Thomas N Wight
Journal:  Am J Respir Cell Mol Biol       Date:  2004-02-05       Impact factor: 6.914

9.  Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma.

Authors:  J Bousquet; P Chanez; J Y Lacoste; I Enander; P Venge; C Peterson; S Ahlstedt; F B Michel; P Godard
Journal:  J Allergy Clin Immunol       Date:  1991-10       Impact factor: 10.793

10.  Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma.

Authors:  Shigeki Katoh; Naoki Ishii; Atsuya Nobumoto; Keisuke Takeshita; Shu-Yan Dai; Rika Shinonaga; Toshiro Niki; Nozomu Nishi; Akira Tominaga; Akira Yamauchi; Mitsuomi Hirashima
Journal:  Am J Respir Crit Care Med       Date:  2007-04-19       Impact factor: 21.405

View more
  3 in total

1.  Treatment with the hyaluronic Acid synthesis inhibitor 4-methylumbelliferone suppresses LPS-induced lung inflammation.

Authors:  Robert J McKallip; Hao Ban; Olga N Uchakina
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

Review 2.  Lung Hyaluronasome: Involvement of Low Molecular Weight Ha (Lmw-Ha) in Innate Immunity.

Authors:  Antony Hoarau; Myriam Polette; Christelle Coraux
Journal:  Biomolecules       Date:  2022-04-30

3.  Presence of hyaluronan in lung alveoli in severe Covid-19: An opening for new treatment options?

Authors:  Urban Hellman; Mats G Karlsson; Anna Engström-Laurent; Sara Cajander; Luiza Dorofte; Clas Ahlm; Claude Laurent; Anders Blomberg
Journal:  J Biol Chem       Date:  2020-09-25       Impact factor: 5.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.